Copay Assistance Programs, and Their Trackers, Stay in the Spotlight
The use of tracking systems — such as copay accumulators and copay maximizers — to scrutinize patients’ use of drug manufacturer copay assistance programs is causing controversy inside and outside of the federal government, as well as concerns among physicians and patients. “These programs harm patients by discouraging the appropriate utilization of specialty therapies and […]